Leonetti G, Cuspidi C, Sampieri L, Terzoli L, Zanchetti A
J Cardiovasc Pharmacol. 1982;4 Suppl 3:S319-24.
The acute effects of two calcium channel blockers, nifedipine and verapamil, were compared in eight normotensive subjects and eight patients with essential hypertension. Nifedipine 10 mg and verapamil 160 mg orally had no effect on blood pressure of normal subjects, but reduced systolic and diastolic pressures of hypertensive patients to the same extent. The blood pressure reduction caused by nifedipine was more prompt and of lesser duration than that caused by verapamil. In both normal subjects and hypertensive patients nifedipine caused a transient rise in heart rate and plasma renin activity, and plasma catecholamines showed a tendency to increase; verapamil did not affect these variables. Nifedipine induced a marked increase in urine volume and renal sodium excretion in hypertensive patients, with a much smaller change in normotensives. Verapamil did not influence water and sodium excretion in either direction. Thus, this study shows similarities and differences between the effects induced by acute oral administration of the most-used vasodilating calcium antagonists.
在8名血压正常的受试者和8名原发性高血压患者中比较了两种钙通道阻滞剂硝苯地平和维拉帕米的急性效应。口服10毫克硝苯地平和160毫克维拉帕米对正常受试者的血压没有影响,但能同等程度地降低高血压患者的收缩压和舒张压。硝苯地平引起的血压降低比维拉帕米更迅速,但持续时间更短。在正常受试者和高血压患者中,硝苯地平都会引起心率和血浆肾素活性的短暂升高,血浆儿茶酚胺有增加的趋势;维拉帕米对这些变量没有影响。硝苯地平使高血压患者的尿量和肾钠排泄显著增加,而血压正常者的变化则小得多。维拉帕米对水和钠的排泄没有任何影响。因此,本研究显示了最常用的血管舒张性钙拮抗剂急性口服所诱导效应之间的异同。